Skip to main content
SpringerLink
Log in

Risk stratification after myocardial infarction: Role of electrical instability, ischemia, and left ventricular function

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The problem of risk stratification after myocardial infarction is reviewed. There are three major complications: new ischemic events, congestive heart failure, and malignant arrhythmias and sudden death, related to the presence of residual ischemia, left ventricular dysfunction, and electrical instability. The bidirectional interactions among these three factors is analyzed. The risk is in the middle of a triangle, the three angles of which are the above-mentioned factors. All the “satellite” factors that appear from all three angles are presented. Furthermore, the most important parameters and techniques employed to detect risk, multifactorial approach of risk stratification, and changes of risk stratification in the thrombolytic era are briefly reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Goldstein S, Bayés de Luna A, Guindo J.Sudden Death. Mount Kisko, NY: Futura, 1994, in press.

    Google Scholar 

  2. Kurlsberg RP, Penkoske PA, Cryer PE, et al. Rapid activation of the sympathetic nervous system following coronary artery occlusion: Relationship to infarct size, site and haemodynamic impact.Cardiovasc Res 1979;13:523–531.

    Google Scholar 

  3. Hoffman BF, Siefens AA, Cranefield PF, Brooks CMC. The effect of epinephrine and norepinephrine on ventricular vulnerability.Circ Res 1955;3:140–146.

    Google Scholar 

  4. Opie LH, Coetzee WA, Dennis SC, et al. A potential role of calcium ions in early ischemia and reperfusion arrhythmias.Ann NY Acad Sci 1988;522:464–477.

    Google Scholar 

  5. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effect of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors.J Am Coll Cardiol 1992;19:1622–1633.

    Google Scholar 

  6. Opie LH, Clusin WT. Cellular mechanisms for ischemic ventricular arrhythmias.Ann Rev Med 1990;41:231–238.

    Google Scholar 

  7. Rosen M, Palti Y.Lethal Arrhythmias Resulting from Myocardial Ischemia and Infarction. Boston: Kluwer Academic, 1989.

    Google Scholar 

  8. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: The Framingham study.Am Heart J 1987;113:799–804.

    Google Scholar 

  9. Kannel WB. Silent myocardial ischemia and infarction: Insights from the Framingham study.Clin Cardiol 1986;4:583–592.

    Google Scholar 

  10. Kannel WB, Thomas HE. Sudden coronary death: The Framingham study.Ann NY Acad Sci 1982;382:3–21.

    Google Scholar 

  11. Bayés de Luna A, Coumel Ph, Leclercq JF. Ambulatory sudden death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases.Am Heart J 1989;117:151–159.

    Google Scholar 

  12. Hauser AM, Gangadharan V, Ramos RG, Gordon S, Timmis GC. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: Echocardiographic observations during coronary angioplasty.J Am Coll Cardiol 1987;5:193–197.

    Google Scholar 

  13. Tzivoni D, Keren A, Granot H, Gottlieb S, Benhorin J, Stern S. Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina.Am Heart J 1983;105:323–325.

    Google Scholar 

  14. Bayés de Luna A, Carreras F, Cladellas M, Oca F, Sagués F, García Moll M. Holter ECG study of the electrocardiographic phenomena in Prinzmetal angina attacks with emphasis on the study of ventricular arrhythmias.J Electrocardiol 1985;18:267–276.

    Google Scholar 

  15. Meinertz T, Zehender M, Hohnloser S, Just H. Prevalence of ventricular arrhythmias during silent myocardial ischemia.Cardiovasc Rev Rep 1988;110(Suppl A):34–38.

    Google Scholar 

  16. Fintel DJ, Platia EV. Exercise testing and cardiac arrhythmias. In: Platia EV, ed.Cardiac Arrhythmias: Nonpharmacological Approach. Philadelphia: JB Lippincott, 1987:28–35.

    Google Scholar 

  17. Camacho AM, Guindo J, Bayés de Luna A. Usefulness of silent subendocardial ischemia detected by ST-segment depression in postmyocardial infarction patients as a predictor of ventricular arrhythmias.Am J Cardiol 1992;69:1243–1244.

    Google Scholar 

  18. Davies MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death.N Engl J Med 1984;310:1137–40.

    Google Scholar 

  19. Vasalle M. Cardiac pacemaker potential at different extra and intracellular K concentrations.Am J Physiol 1965;208:770–775.

    Google Scholar 

  20. Wit AL, Rosen MR. Afterdepolarizations and triggered activity. In: Fozzard HA et al., eds.The Heart and Cardiovascular System. New York: Raven Press, 1986:1449–1490.

    Google Scholar 

  21. Eisner DA, Lederer WJ. Inotropic and arrhythmogenic effects of potassium depleted solutions on mammalian cardiac muscle.J Physiol 1979;204:255–277.

    Google Scholar 

  22. Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med 1989;321:406–421.

    Google Scholar 

  23. Di Bianco R, Shabetai R, Kostuk W, et al. for the Milrinone Multicenter Trial Group. A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure.N Engl J Med 1989;320:677–683.

    Google Scholar 

  24. De Bakker JMT, Van Capelle FJL, Janse ML, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: Electrophysiologic and anatomic correlations.Circulation 1988;77:589–606.

    Google Scholar 

  25. Janse MJ, Bakker JMT, Opthof BT. Pathogenesis of ventricular arrhythmias in heart failure. In: Brachmann J, Dietz R, Kübler W, eds.Heart Failure and Arrhythmias. Heidelberg: Springer Verlag, 1990.

    Google Scholar 

  26. Covell WJ, Lab MJ, Pavelec R. Mechanical induction of paired action potentials in intact heart in situ.J Physiol (Lond) 1981;320:34P.

    Google Scholar 

  27. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction.N Engl J Med 1983;309:331–336.

    Google Scholar 

  28. Bigger JT, Fleixx JL, Kleiger R, et al. The relationship among ventricular arrhythmias, left ventricular dysfunction and mortality in the two years after myocardial infarction.Circulation 1984;69:250–258.

    Google Scholar 

  29. Packer M: Sudden unexpected death in patients with congestive heart failure. A second frontier.Circulation 1985;72:681.

    Google Scholar 

  30. White HD, Norris RM, Brown M, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation 1987;76:44–51.

    Google Scholar 

  31. The CONSENSUS Trial Study Group. The effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).N Engl J Med 1987;316:1429.

    Google Scholar 

  32. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure.N Engl J Med 1991;325:293–302.

    Google Scholar 

  33. Cohn JN, Jonshon GR, Shabetai R, et al. Ejection fraction, peak exercise consumption, cardiothoracic index, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.Circulation 1993;87:V15-V16.

    Google Scholar 

  34. Pedretti R, Etro M, Laporta A, et al. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained ventricular tachycardia.Am J Cardiol 1993;71:1131–1141.

    Google Scholar 

  35. Richards DA, Byth K, Ross DL, et al. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction?Circulation 1991;83:756–763.

    Google Scholar 

  36. Kuchar DL, Thorburn CW, Sammel NL, et al. Prediction of serious arrhythmic events after myocardial infarction: Signal-averaged ECG, Holter monitoring and radionuclide ventriculography.J Am Coll Cardiol 1990;15:724–728.

    Google Scholar 

  37. Cripps TR, Bennet ED, Camm AJ, et al. High gain signal-averaged electrocardiogram combined with 24-hour Holter recording in patients early after myocardial infarction for bedside prediction of arrhythmic events.Br Heart J 1988;60:181–187.

    Google Scholar 

  38. Gomes JA, Winters SL, Stewart D, et al. A new non-invasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring.J Am Coll Cardiol 1987;10:349–357.

    Google Scholar 

  39. El-Sherif N, Ursell SN, Bekheith S, et al. Prognostic significance of the signal-averaged ECG depends on the time of recording in the postinfarction period.Am Heart J 1989;118:256–264.

    Google Scholar 

  40. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged ECG.J Am Coll Cardiol 1991;18:687–697.

    Google Scholar 

  41. Steinberg JS, Regan A, Sciacca RR, et al. Predicting arrhythmic events after myocardial infarction using signal-averaged ECG.Am J Cardiol 1992;69:13–21.

    Google Scholar 

  42. Kulick D, Rahimtoola S. Risk stratification in survivors of acute myocardial infarction: Routine cardiac catheterization and angiography is a reasonable approach in most patients.Am Heart J 1991;121:641–655.

    Google Scholar 

  43. Arnold AER, Simoons ML, Detry JMR, von Essen R, et al. for the European Cooperative Study Group. Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: Is there a need for coronary angiography?Eur Heart J 1993;14:306–315.

    Google Scholar 

  44. Farrell T, Bashir Y, Poloniecki J, Ward D, Cam AJ. The effects of thrombolysis on risk stratification for arrhythmic events in post infarction patients (abstr).J Am Coll Cardiol 1991;17:17.

    Google Scholar 

  45. Zaret BL, Wackers, FJ, Terrin M, Ross R, Knatterud G, Braunwald E, and the TIMI Investigators. Does left ventricular ejection fraction following thrombolytic therapy have the same prognostic impact described in the prethrombolytic era? Results of the TIMI II trial (abstr).J Am Coll Cardiol 1991;17:214.

    Google Scholar 

  46. Theroux P, Morissette D, Juneau M, Guise P, Pelletier G, Waters DD. Influence of fibrinolysis and percutaneous transluminal coronary angioplasty on frequency of ventricular premature complexes.Am J Cardiol 1989:63:797–805.

    Google Scholar 

  47. Turitto G, Risa AL, Zanchi E, Prati PL. The signal-averaged electrocardiogram and ventricular arrhythmias after thrombolysis for acute myocardial infarction.J Am Coll Cardiol 1990;15:1270–1276.

    Google Scholar 

  48. Breithardt G, Borggrefe M, Karbenn U. Late potentials as predictors of risk after thrombolytic treatment?Br Heart J 1990;64:174–176.

    Google Scholar 

  49. Gang ES, Lew AS, Hong M, Wang FZ, Siebert CA, Peter T. Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction.N Engl J Med 1989;321:712–716.

    Google Scholar 

  50. Moreno FL, Karagounis L, Ipsen S, Marshall H Anderson JL. Thrombolysis-related early reperfusion reduces ECG late potentials after acute myocardial infarction (abstr).J Am Coll Cardiol 1991;17:312.

    Google Scholar 

  51. Kersschot IE, Brugada P, Ramentol M, et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: A prospective, randomized study.J Am Coll Cardiol 1986;7:1234.

    Google Scholar 

  52. McComb JM, Gold HK, Leinbach RC, Newell JB, Ruskin JN, Garan H. Electrically induced ventricular arrhythmias in acute myocardial infarction treated with thrombolytic agents.Am J Cardiol 1988;62:186–191.

    Google Scholar 

  53. Bourke JP, Young AA, Richards DAB, Uther J. Reduction of incidence of ventricular tachycardia after myocardial infarction by treatment with streptokinase during infarct evolution.J Am Coll Cardiol 1990;16:1703–1710.

    Google Scholar 

  54. Sager T, Perlmutter RA, Rosenfeld LA, McPherson CA, Wackers FJT, Batsford WP. Electrophysiological effects of thrombolytic therapy in patients with transmural myocardial infarction complicated by left ventricular aneurysm formation.J Am Coll Cardiol 1988;112:19–24.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology and Cardiac Surgery. Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Avda. San Antoni Maria Claret 167, 08025, Barcelona, Spain

    A. Bayés-de-Luna, X. Viñolas, J. Guindo & A. Bayés-Genis

Authors
  1. A. Bayés-de-Luna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Viñolas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Guindo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Bayés-Genis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayés-de-Luna, A., Viñolas, X., Guindo, J. et al. Risk stratification after myocardial infarction: Role of electrical instability, ischemia, and left ventricular function. Cardiovasc Drug Ther 8 (Suppl 2), 335–343 (1994). https://doi.org/10.1007/BF00877318

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00877318

Key words

Search

Navigation